Phagos
Last verified 2026-06-12. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $27.0Mattributed |
|---|---|
| Latest round | series-a, $27.0M, 2025-10-01attributed |
| Founded | unknown |
| Headquarters | Paris |
| Industry | bio |
| Stage | series-a |
| Website | phagos.com |
Phagos develops AI-designed bacteriophage therapies as a precise, sustainable alternative to antibiotics for bacterial infections in livestock. It serves chicken, cattle, swine, and shrimp farms worldwide. Its Alphagos platform pairs microbiology with AI to produce personalized phage treatments in about two months.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-10-01 | series-a | $27.0M | undisclosed |
Detected tech stack
doubleclick floodlight, framer sites, google analytics, google tag manager, hsts, http/3, lucky orange, mysql, php, react 16.13.1, wordpress
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $27.0M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $27.0M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | phagos.com, read 2026-06-12 |
| Description | self-reported | phagos.com, read 2026-06-12 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.